Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
54.37 USD | +0.54% | +4.46% | -13.41% |
05-07 | Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates | MT |
05-01 | TD Cowen Adjusts Price Target on Incyte to $80 From $88 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.41% | 12.14B | |
-2.52% | 88.14B | |
+3.29% | 40.44B | |
-15.40% | 32.24B | |
+51.96% | 24.39B | |
-14.35% | 15.59B | |
-39.65% | 12.3B | |
-6.52% | 12.18B | |
+5.17% | 8.87B | |
-7.13% | 8.41B |
- Stock Market
- Equities
- INCY Stock
- News Incyte Corporation
- Incyte : Q4 Adjusted Earnings, Revenue Rise